View the LUCITENO registration information details.
Back to drug list
ItemsDrug Registration information
ID1802
No1802
Brand NameLUCITENO
IngredientsTENOFOVIR ALAFENAMIDE 25 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 30'S/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE TREATMENT OF CHRONIC HEPATITIS B VIRUS INFECTION IN ADULTS AND PEDIATRIC PATIENTS 6 YEARS OF AGE AND OLDER AND WEIGHING AT LEAST 25 KG WITH COMPENSATED LIVER DISEASE
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionORANGE TABLETS, LETTER LUS ON ONE SIDE AND PLAIN ON THE OTHER
Note
License OwnerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
ManufacturerLUCIUS PHARMACEUTICALS(LAO) CO.,LTD
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No09 L 1210/24
FDD Registration Date02/10/2024
Expiry Date01/10/2029
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA